Literature DB >> 1946395

Direct binding of a synthetic multichain polypeptide to class II major histocompatibility complex molecules on antigen-presenting cells and stimulation of a specific T-cell line require processing of the polypeptide.

E Zisman1, M Sela, E Mozes.   

Abstract

T-cell activation involves the recognition of foreign antigens as a complex with self-major histocompatibility complex (MHC) proteins on the surface of antigen-presenting cells (APC). Protein antigens usually require uptake by the APC and processing that results in the generation of peptide fragments. The branched synthetic polypeptide (Tyr, Glu)-Ala--Lys was chosen as a model antigen to follow the processing requirements, leading to T-cell activation. It has been demonstrated, by using fixed APC and various inhibitors of proteases, that (Tyr, Glu)-Ala--Lys has to be processed to stimulate a (Tyr, Glu)-Ala--Lys-specific T-cell line of C3H.SW (H-2b) origin to proliferate. To determine whether processing of (Tyr,Glu)-Ala--Lys is required to allow its association with the MHC class II molecules, biotin was covalently attached to it. Binding of the biotinylated (Tyr,Glu)-Ala--Lys to MHC class II gene products on the surface of intact normal APC was directly detected by phycoerythrin-streptavidin. The specificity of the binding was confirmed by its inhibition with anti-I-Ab antibodies as well as with excess of nonlabeled (Tyr,Glu)-Ala--Lys. Furthermore, introducing several inhibitors of proteases to the binding assay, we could substantiate that the proteolysis of (Tyr,Glu)-Ala--Lys is required to allow association of the resulting peptidyl T-cell epitopes with the MHC class II molecules themselves. The presence of the biotin moiety in the resulting peptides suggests that the T-cell epitopes of (Tyr,Glu)-Ala--Lys contain the N-terminal portion of the side chains of the branched polypeptide. An apparent Kd of 8.05 x 10(-8) M was determined, and optimal binding was detected after 10 hr of incubation with the antigen. The latter phenomenon is not due to slow uptake, since uptake of (Tyr,Glu)-Ala--Lys occurs mainly during the first 30 min of incubation, but rather reflects the events of processing that precede MHC interaction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1946395      PMCID: PMC52795          DOI: 10.1073/pnas.88.21.9738

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine.

Authors:  M SELA; S FUCHS; R ARNON
Journal:  Biochem J       Date:  1962-10       Impact factor: 3.857

2.  The molecular basis of the requirement for antigen processing of pigeon cytochrome c prior to T cell activation.

Authors:  Z Kovac; R H Schwartz
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

3.  Antigen conformation determines processing requirements for T-cell activation.

Authors:  H Z Streicher; I J Berkower; M Busch; F R Gurd; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas.

Authors:  P M Allen; E R Unanue
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

5.  Requirements for the processing of antigen by antigen-presenting B cells. II. Biochemical comparison of the fate of antigen in B cell tumors and macrophages.

Authors:  H M Grey; S M Colon; R W Chesnut
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

6.  Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells.

Authors:  H K Ziegler; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells.

Authors:  C A Janeway; P J Conrad; E A Lerner; J Babich; P Wettstein; D B Murphy
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

8.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.

Authors:  R Shimonkevitz; J Kappler; P Marrack; H Grey
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

9.  Genetic control of the immune response. Mapping of the Ir-1 locus.

Authors:  H O McDevitt; B D Deak; D C Shreffler; J Klein; J H Stimpfling; G D Snell
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

10.  Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice.

Authors:  H O McDevitt; M Sela
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  4 in total

1.  Ia-antigen-T-cell interactions for a thymus-independent antigen composed of D amino acids.

Authors:  E Zisman; M Dayan; M Sela; E Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

2.  Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein.

Authors:  D Teitelbaum; R Milo; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

Authors:  M Fridkis-Hareli; D Teitelbaum; E Gurevich; I Pecht; C Brautbar; O J Kwon; T Brenner; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

4.  Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines.

Authors:  Kay Lockyer; Fang Gao; Jeremy P Derrick; Barbara Bolgiano
Journal:  Vaccine       Date:  2015-01-29       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.